DK1214097T3 - Nukleinsyrer kodende for polyepitop-polypeptider - Google Patents
Nukleinsyrer kodende for polyepitop-polypeptiderInfo
- Publication number
- DK1214097T3 DK1214097T3 DK00965119T DK00965119T DK1214097T3 DK 1214097 T3 DK1214097 T3 DK 1214097T3 DK 00965119 T DK00965119 T DK 00965119T DK 00965119 T DK00965119 T DK 00965119T DK 1214097 T3 DK1214097 T3 DK 1214097T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acids
- acids encoding
- polyepitope polypeptides
- encoding polyepitope
- polypeptides
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39853499A | 1999-09-16 | 1999-09-16 | |
US15466599P | 1999-09-16 | 1999-09-16 | |
US45817399A | 1999-12-09 | 1999-12-09 | |
US16984699P | 1999-12-09 | 1999-12-09 | |
PCT/US2000/025559 WO2001019408A1 (en) | 1999-09-16 | 2000-09-18 | Nucleic acids encoding polyepitope polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1214097T3 true DK1214097T3 (da) | 2009-11-16 |
Family
ID=27496146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00965119T DK1214097T3 (da) | 1999-09-16 | 2000-09-18 | Nukleinsyrer kodende for polyepitop-polypeptider |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP1214097B3 (ja) |
JP (1) | JP2003509035A (ja) |
AU (1) | AU785319B2 (ja) |
CA (1) | CA2384987A1 (ja) |
CY (1) | CY1109699T1 (ja) |
DE (1) | DE60042556D1 (ja) |
DK (1) | DK1214097T3 (ja) |
ES (1) | ES2330078T3 (ja) |
PT (1) | PT1214097E (ja) |
WO (1) | WO2001019408A1 (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2399058A1 (en) * | 2000-02-02 | 2001-08-09 | Transgene S.A. | Targeting peptides |
FR2824326B1 (fr) * | 2001-05-04 | 2004-03-19 | Commissariat Energie Atomique | Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications |
GB0118532D0 (en) | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
US8637305B2 (en) | 2001-11-07 | 2014-01-28 | Mannkind Corporation | Expression vectors encoding epitopes of target-associated antigens and methods for their design |
AU2003229429A1 (en) * | 2002-05-07 | 2003-11-11 | Aventis Pasteur, Ltd. | Polyepitopes and mini-genes for cancer treatment |
AU2002950183A0 (en) * | 2002-07-12 | 2002-09-12 | The Council Of The Queensland Institute Of Medical Research | Expression of hydrophobic proteins |
CA2502696A1 (en) * | 2002-10-21 | 2004-05-06 | Mgi Pharma Biologics, Inc. | Compositions and methods for treating human papillomavirus-mediated disease |
ATE520708T1 (de) | 2003-03-28 | 2011-09-15 | Us Gov Health & Human Serv | Immunogenetische hiv-1 multi-klade, multivalente konstrukte und deren verwendung |
JP2007537975A (ja) * | 2003-06-10 | 2007-12-27 | ザ ユニバーシティー オブ メルボルン | 免疫調節性組成物、それらについての使用方法およびそれらの製造のための方法 |
US8877206B2 (en) | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
AU2009236306B2 (en) | 2008-04-17 | 2015-04-02 | Pds Biotechnology Corporation | Stimulation of an immune response by enantiomers of cationic lipids |
EA025280B1 (ru) * | 2010-03-09 | 2016-12-30 | Амир Максютов | Полиэпитопные конструкции и способы их получения и применения |
CN103180343B (zh) * | 2010-08-13 | 2016-01-20 | 株式会社吉耐森 | 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物 |
CN105463001A (zh) * | 2010-08-13 | 2016-04-06 | 株式会社吉耐森 | 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物 |
CN105463000B (zh) * | 2010-08-13 | 2021-06-01 | 株式会社吉耐森 | 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物 |
CA2836494C (en) | 2011-05-24 | 2023-01-03 | Biontech Ag | Individualized vaccines for cancer |
RS59369B1 (sr) | 2011-05-24 | 2019-11-29 | Biontech Rna Pharmaceuticals Gmbh | Individualizovane vakcine protiv kancera |
JP2015530413A (ja) | 2012-09-21 | 2015-10-15 | ベデュ−アッド,フランク | 改良されたワクチン組成物および使用方法 |
MA40458A (fr) | 2014-08-15 | 2016-02-18 | Genexine Inc | Méthodes de traitement du cancer du col de l'utérus |
BR112017009177A2 (pt) * | 2014-11-04 | 2018-12-11 | Janssen Vaccines & Prevention B.V. | vacinas terapêuticas contra hpv16 |
EP4092112A1 (en) | 2015-11-13 | 2022-11-23 | PDS Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
EP3386593A4 (en) * | 2015-12-09 | 2019-07-24 | Admedus Vaccines Pty Ltd | IMMUNOMODULATING COMPOSITION FOR TREATMENT |
AU2017340407A1 (en) * | 2016-10-05 | 2019-05-02 | Pds Biotechnology Corporation | Novel HPV16 non HLA-restricted T-cell vaccines, compositions and methods of use thereof |
AU2017386682A1 (en) * | 2016-12-28 | 2019-07-25 | Invvax, Inc. | Influenza vaccines |
CN111093691A (zh) * | 2017-04-03 | 2020-05-01 | 内恩疗法公司 | 蛋白质抗原及其用途 |
US20210393757A1 (en) * | 2018-10-01 | 2021-12-23 | The Wistar Institute | Melanoma Canine Vaccine Compositions and Methods of Use Thereof |
PE20231054A1 (es) | 2020-04-24 | 2023-07-11 | Genexine Inc | Metodo para tratamiento del cancer cervicouterino |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0436634A1 (en) * | 1988-10-03 | 1991-07-17 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
KR910016343A (ko) * | 1990-03-20 | 1991-11-05 | 스타인, 부그 | 사람 파필로마바이러스(hpv) 16 단백질의 혈청반응성 에피토프 |
US5753233A (en) * | 1990-05-10 | 1998-05-19 | Behring Diagnostics Gmbh | Seroreactive epitopes on proteins of human papilloma-virus (HPV) 18 |
DE4015044A1 (de) * | 1990-05-10 | 1991-11-14 | Behringwerke Ag | Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18 |
SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
AU8762991A (en) * | 1990-09-26 | 1992-04-15 | Bristol-Myers Squibb Company | Human papilloma viral protein expression for use in vaccine compositions |
GB9105383D0 (en) * | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
EP0523391B1 (en) * | 1991-07-13 | 2003-03-19 | Dade Behring Marburg GmbH | Use of HPV-16 E6 and E7-gene derived peptides for the diagnostic purpose |
IL105554A (en) * | 1992-05-05 | 1999-08-17 | Univ Leiden | Peptides of human papillomavirus for use in preparations elicit a human T cell response |
EP0671926B1 (en) | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
US5679509A (en) * | 1993-09-28 | 1997-10-21 | University Of New Mexico | Methods and a diagnostic aid for distinguishing a subset of HPV that is associated with an increased risk of developing cervical dysplasia and cervical cancer |
WO1995024929A2 (en) | 1994-03-15 | 1995-09-21 | Brown University Research Foundation | Polymeric gene delivery system |
AUPN015794A0 (en) * | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
US5783567A (en) | 1997-01-22 | 1998-07-21 | Pangaea Pharmaceuticals, Inc. | Microparticles for delivery of nucleic acid |
US6013258A (en) * | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
-
2000
- 2000-09-18 AU AU75891/00A patent/AU785319B2/en not_active Ceased
- 2000-09-18 DE DE60042556T patent/DE60042556D1/de not_active Expired - Lifetime
- 2000-09-18 EP EP00965119A patent/EP1214097B3/en not_active Expired - Lifetime
- 2000-09-18 WO PCT/US2000/025559 patent/WO2001019408A1/en active Application Filing
- 2000-09-18 PT PT00965119T patent/PT1214097E/pt unknown
- 2000-09-18 DK DK00965119T patent/DK1214097T3/da active
- 2000-09-18 JP JP2001523039A patent/JP2003509035A/ja active Pending
- 2000-09-18 EP EP09008339A patent/EP2100620A1/en not_active Withdrawn
- 2000-09-18 CA CA002384987A patent/CA2384987A1/en not_active Abandoned
- 2000-09-18 ES ES00965119T patent/ES2330078T3/es not_active Expired - Lifetime
-
2009
- 2009-10-13 CY CY20091101046T patent/CY1109699T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001019408A9 (en) | 2002-12-05 |
EP1214097B1 (en) | 2009-07-15 |
WO2001019408A1 (en) | 2001-03-22 |
DE60042556D1 (de) | 2011-02-10 |
CA2384987A1 (en) | 2001-03-22 |
JP2003509035A (ja) | 2003-03-11 |
AU7589100A (en) | 2001-04-17 |
CY1109699T1 (el) | 2014-08-13 |
EP1214097A4 (en) | 2005-02-02 |
AU785319B2 (en) | 2007-01-11 |
EP1214097B9 (en) | 2010-05-19 |
EP1214097B3 (en) | 2011-07-20 |
ES2330078T3 (es) | 2009-12-04 |
EP1214097A1 (en) | 2002-06-19 |
PT1214097E (pt) | 2009-10-19 |
EP2100620A1 (en) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1214097T3 (da) | Nukleinsyrer kodende for polyepitop-polypeptider | |
DE60022665D1 (de) | Immunstimulierende nukeinsäuren | |
EE200300107A (et) | Uued retseptori nukleiinhapped ja polüpeptiidid | |
AU2001234944A8 (en) | Novel nucleic acids and polypeptides | |
EP1504099A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES | |
EP1381621A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES | |
EP1432800A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES | |
EP1470238A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES | |
EP1325120A4 (en) | NUCLEIC ACIDS AND POLYPEPTIDES | |
EP1341804A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES | |
DE60015796D1 (de) | Neue aminopropylphosphinsäuren | |
EP1430112A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES | |
EP1276751A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES | |
ATE207112T1 (de) | Tresteruntertaucheinrichtung zur weinherstellung | |
AU8308901A (en) | Novel proteins and nucleic acids encoding same | |
AU1181802A (en) | Novel proteins and nucleic acids encoding same | |
EP1341803A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES | |
FR2791348B1 (fr) | POLYPEPTIDE Npt2B | |
AU2002339862A8 (en) | Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis | |
NO20021614D0 (no) | DNA kodende for PROST 07-polypeptid | |
IL145785A0 (en) | Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same | |
PT1171454E (pt) | Acidos nucleicosos e polipeptidos quimericos do lyssavirus | |
AU3099402A (en) | Novel proteins and nucleic acids encoding same | |
AU2001263005A8 (en) | Novel nucleic acids and polypeptides | |
EP1268762A4 (en) | NEW NUCLEIC ACIDS AND POLYPEPTIDES |